Newron agrees Parkinson's drug deal with Zambon
ZURICH (Reuters) - Italian drug maker Newron has signed a strategic collaboration and licensing deal for its Parkinson's disease drug safinamide with Italian drugs and chemicals maker Zambon which involves Zambon taking a 9.1 percent stake in Newron. Newron said in a statement Zambon would make an initial investment of 20 million euros ($26.2 million) to pay for the completion of the drug's clinical development and applications for marketing approval in Europe and the United States. ...
Source: news.yahoo.com
No comments:
Post a Comment